vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
34.46
-0.68 (-1.94%)
At close: Feb 11, 2026, 4:00 PM EST
34.39
-0.07 (-0.20%)
After-hours: Feb 11, 2026, 4:10 PM EST
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $426.74 million as of February 11, 2026. Its market cap has increased by 362.71% in one year.
Market Cap
426.74M
Enterprise Value
328.60M
1-Year Change
362.71%
Ranking
Category
Stock Price
$34.46
Market Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $426.74M, an increase of 446.23%. That is a compound annual growth rate of 17.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 426.73M | -14.00% |
| Dec 31, 2025 | 496.22M | 445.90% |
| Dec 31, 2024 | 90.90M | 288.02% |
| Dec 29, 2023 | 23.43M | -56.62% |
| Dec 30, 2022 | 54.01M | -18.92% |
| Dec 31, 2021 | 66.61M | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 433.26M |
| Kyverna Therapeutics | 433.04M |
| Vanda Pharmaceuticals | 428.45M |
| PureTech Health | 427.48M |
| Lineage Cell Therapeutics | 425.28M |
| REGENXBIO | 416.63M |
| Assembly Biosciences | 415.20M |
| Enanta Pharmaceuticals | 410.61M |